KATO-III cell

SKU:BHC11100271
Bulk Pricing
Overview
Click light‑blue chips for details

KATO-III cell is a cell line derived from Asian (Male). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent,suspension, Spherical. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Adenocarcinoma
Morphology Spherical
Growth Properties Adherent,suspension
Tissue Stomach
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Options selector
Catalog no. Size
300381 1 cryovial
Field Specification
Species Human
The KATO-III cell line is a human gastric carcinoma model derived from the metastatic site of a poorly differentiated adenocarcinoma. These cells are widely utilized in research focused on gastric cancer, particularly for studying the molecular mechanisms driving tumor progression, drug resistance, and metastasis. The KATO-III cells exhibit an aneuploid karyotype, characterized by multiple chromosomal abnormalities, which contributes to their aggressive cancer phenotype. They are notably p53 deficient, a feature often associated with increased tumorigenicity and altered responses to chemotherapy, making them a valuable tool for investigating the role of p53 in gastric cancer. KATO-III cells grow in suspension and display a rounded morphology. They possess a high capacity for proliferation, making them suitable for various in vitro applications, including drug screening and cytotoxicity assays. These cells are also used in studies of cell signaling pathways, as their aberrant signaling is a hallmark of gastric cancer pathogenesis. Researchers often utilize KATO-III cells to explore the efficacy of novel therapeutic agents, particularly those targeting HER2, EGFR, and other relevant oncogenic pathways. This cell line is essential for advancing our understanding of gastric cancer biology and for developing targeted therapies aimed at improving patient outcomes.

SKU:BHC11100271

  • Protein expression: p53 negative, CEA positive
  • Antigen expression: Blood Type B, Rh+
  • Isoenzymes: PGM3, 1, PGM1, 1, ES-D, 1, AK-1, 1, GLO-1, 2, G6PD, B, Phenotype Frequency Product: 0.0742
  • Tumorigenic: Yes, in cheek pouches of anti thymocyte serum treated hamsters, not tumorigenic in nude mice
  • Karyotype: The stemline chromosome number is hypotetraploid with the 2S component occurring at 6.2%. Nine markers were common to most S metaphases, four markers were less frequent. One (occasionally 2 copies) homogenous staining region (HSR) (t(11,HSR) was present in all metaphases examined, but no double minutes (DM) were detected (Sekiguchi 1978).
  • cultureMedium: Ham's F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
  • supplements: Supplement the medium with 10% FBS
  • dissociationReagent: Accutase
  • doublingTime: 36 hours
  • subculturing: Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium.
  • seedingDensity: 2 x 104 cells/cm2 will result in a confluent monolayer within 2 to 3 days.
  • fluidRenewal: Every 3 to 5 days
  • postThawRecovery: After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours.
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider